Daewon Pharmaceutical Co., Ltd.

KOSE:A003220 Stock Report

Market Cap: ₩312.6b

Daewon Pharmaceutical Dividend

Dividend criteria checks 3/6

Daewon Pharmaceutical is a dividend paying company with a current yield of 2.37% that is well covered by earnings.

Key information

2.4%

Dividend yield

27%

Payout ratio

Industry average yield1.1%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share₩1.11k
Dividend yield forecast in 3Y2.0%

Recent dividend updates

Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Dec 24
Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Recent updates

There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings

Mar 21
There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings

Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Mar 26
Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?

Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?

Mar 07
Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?

Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?

Feb 18
Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?

Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 31
Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?

Jan 13
Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?

Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Dec 24
Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend

Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly

Dec 10
Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly

Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?

Nov 22
Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: A003220 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: A003220's dividend payments have increased, but the company has only paid a dividend for 9 years.


Dividend Yield vs Market

Daewon Pharmaceutical Dividend Yield vs Market
How does A003220 dividend yield compare to the market?
SegmentDividend Yield
Company (A003220)2.4%
Market Bottom 25% (KR)1.0%
Market Top 25% (KR)3.5%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast in 3 Years (A003220)2.0%

Notable Dividend: A003220's dividend (2.37%) is higher than the bottom 25% of dividend payers in the KR market (1%).

High Dividend: A003220's dividend (2.37%) is low compared to the top 25% of dividend payers in the KR market (3.5%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (26.8%), A003220's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (55%), A003220's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.